• Explore /
  • Poster
  • / Quality of life, functioning, and symptoms in patients with previously treated locally advanced or metastatic urothelial carcinoma from EV-301: A randomized phase 3 trial of enfortumab vedotin versus chemotherapy.

Quality of life, functioning, and symptoms in patients with previously treated locally advanced or metastatic urothelial carcinoma from EV-301: A randomized phase 3 trial of enfortumab vedotin versus chemotherapy.

Abstract Video & Slides Poster

Authors

null

Ronac Mamtani

University of Pennsylvania, Philadelphia, PA

Ronac Mamtani , Jonathan E. Rosenberg , Thomas Powles , Guru P. Sonpavde , Yohann Loriot , Ignacio Duran , Jae-Lyun Lee , Nobuaki Matsubara , Christof Vulsteke , Daniel Castellano , Srikala S. Sridhar , Helle Pappot , Begoña P. Valderrama , Howard Gurney , Jens Bedke , Michiel Simon Van Der Heijden , Chunzhang Wu , Zsolt Hepp , Caroline McKay , Daniel P. Petrylak

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Bladder Cancer

Clinical Trial Registration Number

NCT03474107

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 4539)

DOI

10.1200/JCO.2021.39.15_suppl.4539

Abstract #

4539

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Jonathan E. Rosenberg

First Author: Daniel Peter Petrylak

First Author: Peter H. O'Donnell

First Author: Vera Hirsh